Home » CytRx and SynthRx, Galapagos Genomics, Alnylam Pharmaceuticals, Nucleonics and University of California, and Sirna Therapeutics

CytRx and SynthRx, Galapagos Genomics, Alnylam Pharmaceuticals, Nucleonics and University of California, and Sirna Therapeutics

Jun 11, 2004
Premium

CytRx Closes SynthRx Deal

CytRx said this week that it has closed its deal to exclusively license its phase III sickle cell disease drug Flocor, as well as its OptiVax vaccine delivery technology, to SynthRx, a Houston-based startup firm founded and run by Robert Hunter, a CytRx co-founder and chairman of the University of Texas' department of pathology and laboratory medicine.

The assets were leftovers from the time before CytRx acquired Global Genomics and was repositioned as an RNAi therapeutics firm.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Drive Resistance

Gene drives might run into biological resistance, the Economist reports.

Dalí DNA Collected

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Synthetic-Conservation Biology Disconnect

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

This Week in Science

In Science this week: full CRISPR locus integration complex structure, and more.

What's Popular?

In Gene Silencing/Gene Editing

  1. UC Riverside Team Wins $14.9M DARPA Grant for Genetic Mosquito Control Research

  2. Researchers Design, Construct Genome-Wide Sequence-Verified Arrayed CRISPR Library

  3. Bio-Rad Laboratories Aims to Create Genome Editing Tools Pipeline, Starting With ddPCR

    Premium

  4. Cas1-Cas2 Integrase Structures Enable Bacteria to Adapt to New Viruses

  5. Christiana Care, NovellusDx Ink Licensing Deal for Gene-Editing Tech

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.